Abstract | OBJECTIVE: METHODS: RESULTS: CONCLUSION:
|
Authors | Hiroko Shimada, Shigeto Ueda, Toshiaki Saeki, Takashi Shigekawa, Hideki Takeuchi, Eiko Hirokawa, Ikuko Sugitani, Michiko Sugiyama, Takao Takahashi, Kazuo Matsuura, Tomohiko Yamane, Ichiei Kuji, Takahiro Hasebe, Akihiko Osaki |
Journal | Japanese journal of clinical oncology
(Jpn J Clin Oncol)
Vol. 45
Issue 7
Pg. 642-9
(Jul 2015)
ISSN: 1465-3621 [Electronic] England |
PMID | 25989989
(Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: [email protected]. |
Chemical References |
- 130-nm albumin-bound paclitaxel
- Albumins
- Biomarkers, Tumor
- Radiopharmaceuticals
- Taxoids
- Fluorodeoxyglucose F18
- Docetaxel
- Epirubicin
- Cyclophosphamide
- Paclitaxel
|
Topics |
- Adult
- Aged
- Albumins
(administration & dosage, adverse effects)
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Biomarkers, Tumor
(analysis)
- Breast Neoplasms
(drug therapy, pathology)
- Cyclophosphamide
(administration & dosage, adverse effects)
- Docetaxel
- Drug Administration Schedule
- Epirubicin
(administration & dosage, adverse effects)
- Female
- Fluorodeoxyglucose F18
- Humans
- Infusions, Intravenous
- Kaplan-Meier Estimate
- Middle Aged
- Nanoparticles
- Neoadjuvant Therapy
(methods)
- Neoplasm Staging
- Paclitaxel
(administration & dosage, adverse effects)
- Positron-Emission Tomography
(methods)
- Radiopharmaceuticals
- Taxoids
(administration & dosage, adverse effects)
- Treatment Outcome
|